Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05109 (
S100A8
)
1,212
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proteins of S100 group, produced by phagocytes represent endogenous activators of innate immune responses. Role of these proteins in the etiopathogenesis of cholelithiasis remains unknown. The studies aimed at the morphometric evaluation of
S100A8
and S100A9 protein expression in gallbladder mucosa in patients with acute and chronic calculous cholecystitis (n = 71). The presence of proteins was detected by immunohistochemistry while quantitative analysis employed the spatial visualization technique. We found the immunopositive expression of the two studied S100 proteins in neutrophils and monocytes/macrophages of the gallbladder's wall and a higher expression in
acute cholecystitis
. Quantitative study revealed higher immunoexpression of S100A9 over
S100A8
in both studied groups of patients. Moreover, a reciprocal linear relationship between the expression of the studied proteins and a positive correlation between expression of either
S100A8
or S100A9 and inflammatory activity (grading) in the gallbladder wall were found. The expression of
S100A8
protein in the chronic cholecystitis group and in older patients correlated with leukocytosis, which suggests the role of
S100A8
particularly at the chronic stage of cholecystitis. The obtained results indicated close relationship between
S100A8
and S100A9 proteins in their proinflammatory functions. The increased expression of only one of them can be recognized as a useful index of local inflammatory activity in calculous cholecystitis.
...
PMID:Tissue expression of S100 proteins in gallbladder mucosa of the patients with calculous cholecystitis. 2390 44